Literature DB >> 19906119

Cytoprotective effects of adenosine and inosine in an in vitro model of acute tubular necrosis.

Katalin Módis1, Domokos Gero, Nóra Nagy, Petra Szoleczky, Zoltán Dóri Tóth, Csaba Szabó.   

Abstract

BACKGROUND AND
PURPOSE: We have established an in vitro model of acute tubular necrosis in rat kidney tubular cells, using combined oxygen-glucose deprivation (COGD) and screened a library of 1280 pharmacologically active compounds for cytoprotective effects. EXPERIMENTAL APPROACH: We used in vitro cell-based, high throughput, screening, with cells subjected to COGD using hypoxia chambers, followed by re-oxygenation. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and the Alamar Blue assay measured mitochondrial respiration and the lactate dehydrogenase assay was used to indicate cell death. ATP levels were measured using a luminometric assay. KEY
RESULTS: Adenosine markedly reduced cellular injury, with maximal cytoprotective effect at 100 microM and an EC(50) value of 14 microM. Inosine was also found to be cytoprotective. The selective A(3) adenosine receptor antagonist MRS 1523 attenuated the protective effects of adenosine and inosine, while an A(3) adenosine receptor agonist provided a partial protective effect. Adenosine deaminase inhibition attenuated the cytoprotective effect of adenosine but not of inosine during COGD. Inhibition of adenosine kinase reduced the protective effects of both adenosine and inosine during COGD. Pretreatment of the cells with adenosine or inosine markedly protected against the fall in cellular ATP content in the cells subjected to COGD. CONCLUSIONS AND IMPLICATIONS: The cytoprotection elicited by adenosine and inosine in a model of renal ischaemia involved both interactions with cell surface adenosine receptors on renal tubular epithelial cells and intracellular metabolism and conversion of adenosine to ATP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19906119      PMCID: PMC2795223          DOI: 10.1111/j.1476-5381.2009.00432.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  63 in total

1.  Renal interstitial adenosine metabolism during ischemia in dogs.

Authors:  A Nishiyama; S Kimura; H He; K Miura; M Rahman; Y Fujisawa; T Fukui; Y Abe
Journal:  Am J Physiol Renal Physiol       Date:  2001-02

Review 2.  Emerging therapies for acute renal failure.

Authors:  C L Edelstein; H Ling; A Wangsiripaisan; R W Schrier
Journal:  Am J Kidney Dis       Date:  1997-11       Impact factor: 8.860

3.  Purines inhibit poly(ADP-ribose) polymerase activation and modulate oxidant-induced cell death.

Authors:  L Virág; C Szabó
Journal:  FASEB J       Date:  2001-01       Impact factor: 5.191

4.  Inosine mediates the protective effect of adenosine in rat astrocyte cultures subjected to combined glucose-oxygen deprivation.

Authors:  S E Haun; J E Segeleon; V L Trapp; M A Clotz; L A Horrocks
Journal:  J Neurochem       Date:  1996-11       Impact factor: 5.372

5.  Systemic adenosine given after ischemia protects renal function via A(2a) adenosine receptor activation.

Authors:  H T Lee; C W Emala
Journal:  Am J Kidney Dis       Date:  2001-09       Impact factor: 8.860

Review 6.  Novel approaches to the treatment of acute renal failure.

Authors:  R Venkataraman; J A Kellum
Journal:  Expert Opin Investig Drugs       Date:  2000-11       Impact factor: 6.206

7.  Enhanced protection from renal ischemia-reperfusion [correction of ischemia:reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition.

Authors:  M D Okusa; J Linden; L Huang; D L Rosin; D F Smith; G Sullivan
Journal:  Kidney Int       Date:  2001-06       Impact factor: 10.612

8.  Short- and long-term A3 adenosine receptor activation inhibits the Na+/H+ exchanger NHE3 activity and expression in opossum kidney cells.

Authors:  Francesca Di Sole; Robert Cerull; Victor Babich; Valeria Casavola; Corinna Helmle-Roth; Gerhard Burckhardt
Journal:  J Cell Physiol       Date:  2008-07       Impact factor: 6.384

Review 9.  The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury.

Authors:  C Szabó
Journal:  Shock       Date:  1996-08       Impact factor: 3.454

10.  Adenine nucleotide metabolites are beneficial for recovery of cardiac contractile force after hypoxia.

Authors:  S Takeo; K Tanonaka; K Miyake; M Imago
Journal:  J Mol Cell Cardiol       Date:  1988-03       Impact factor: 5.000

View more
  18 in total

Review 1.  Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects.

Authors:  Katalin Módis; Eelke M Bos; Enrico Calzia; Harry van Goor; Ciro Coletta; Andreas Papapetropoulos; Mark R Hellmich; Peter Radermacher; Frédéric Bouillaud; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

2.  Cardioprotective effects of hydrogen sulfide.

Authors:  Gábor Szabó; Gábor Veres; Tamás Radovits; Domokos Gero; Katalin Módis; Christiane Miesel-Gröschel; Ferenc Horkay; Matthias Karck; Csaba Szabó
Journal:  Nitric Oxide       Date:  2010-11-19       Impact factor: 4.427

3.  Adenosine A1 receptor-dependent antinociception induced by inosine in mice: pharmacological, genetic and biochemical aspects.

Authors:  Francisney Pinto Nascimento; Sérgio José Macedo-Júnior; Fabrício Alano Pamplona; Murilo Luiz-Cerutti; Marina Machado Córdova; Leandra Constantino; Carla Inês Tasca; Rafael Cypriano Dutra; João B Calixto; Allison Reid; Jana Sawynok; Adair Roberto Soares Santos
Journal:  Mol Neurobiol       Date:  2014-07-27       Impact factor: 5.590

4.  Modulation of poly(ADP-ribose) polymerase-1 (PARP-1)-mediated oxidative cell injury by ring finger protein 146 (RNF146) in cardiac myocytes.

Authors:  Domokos Gerö; Petra Szoleczky; Athanasia Chatzianastasiou; Andreas Papapetropoulos; Csaba Szabo
Journal:  Mol Med       Date:  2014-07-31       Impact factor: 6.354

5.  Identification of agents that reduce renal hypoxia-reoxygenation injury using cell-based screening: purine nucleosides are alternative energy sources in LLC-PK1 cells during hypoxia.

Authors:  Petra Szoleczky; Katalin Módis; Nóra Nagy; Zoltán Dóri Tóth; Douglas DeWitt; Csaba Szabó; Domokos Gero
Journal:  Arch Biochem Biophys       Date:  2011-11-11       Impact factor: 4.013

6.  Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function.

Authors:  Kunihiro Suzuki; Gabor Olah; Katalin Modis; Ciro Coletta; Gabriella Kulp; Domokos Gerö; Petra Szoleczky; Tuanjie Chang; Zongmin Zhou; Lingyun Wu; Rui Wang; Andreas Papapetropoulos; Csaba Szabo
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-01       Impact factor: 11.205

7.  Anti-inflammatory effects of purine nucleosides, adenosine and inosine, in a mouse model of pleurisy: evidence for the role of adenosine A2 receptors.

Authors:  Fernanda da Rocha Lapa; Morgana Duarte da Silva; Daniela de Almeida Cabrini; Adair R S Santos
Journal:  Purinergic Signal       Date:  2012-03-29       Impact factor: 3.765

8.  Effects of inosine on reperfusion injury after cardiopulmonary bypass.

Authors:  Gábor Veres; Tamás Radovits; Leila Seres; Ferenc Horkay; Matthias Karck; Gábor Szabó
Journal:  J Cardiothorac Surg       Date:  2010-11-08       Impact factor: 1.637

9.  Protection by inosine in a cellular model of Parkinson's disease.

Authors:  S Cipriani; R Bakshi; M A Schwarzschild
Journal:  Neuroscience       Date:  2014-05-29       Impact factor: 3.590

10.  3-Mercaptopyruvate sulfurtransferase supports endothelial cell angiogenesis and bioenergetics.

Authors:  Armita Abdollahi Govar; Gábor Törő; Peter Szaniszlo; Athanasia Pavlidou; Sofia-Iris Bibli; Ketan Thanki; Vicente A Resto; Celia Chao; Mark R Hellmich; Csaba Szabo; Andreas Papapetropoulos; Katalin Módis
Journal:  Br J Pharmacol       Date:  2019-03-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.